DK1383752T3 - Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser - Google Patents
Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelserInfo
- Publication number
- DK1383752T3 DK1383752T3 DK02727303T DK02727303T DK1383752T3 DK 1383752 T3 DK1383752 T3 DK 1383752T3 DK 02727303 T DK02727303 T DK 02727303T DK 02727303 T DK02727303 T DK 02727303T DK 1383752 T3 DK1383752 T3 DK 1383752T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperidinopropiophenones
- deuterated
- well
- compounds
- illnesses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10123129A DE10123129A1 (de) | 2001-05-02 | 2001-05-02 | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
EP02727303A EP1383752B1 (de) | 2001-05-02 | 2002-04-29 | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1383752T3 true DK1383752T3 (da) | 2005-10-17 |
Family
ID=7684543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02727303T DK1383752T3 (da) | 2001-05-02 | 2002-04-29 | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser |
Country Status (22)
Country | Link |
---|---|
US (1) | US7307091B2 (da) |
EP (1) | EP1383752B1 (da) |
JP (1) | JP4373097B2 (da) |
KR (1) | KR100894846B1 (da) |
CN (2) | CN101002770A (da) |
AT (1) | ATE298324T1 (da) |
AU (1) | AU2002257562B2 (da) |
CA (1) | CA2446890C (da) |
CZ (1) | CZ20033060A3 (da) |
DE (2) | DE10123129A1 (da) |
DK (1) | DK1383752T3 (da) |
ES (1) | ES2244768T3 (da) |
HU (1) | HUP0400077A2 (da) |
IL (1) | IL158668A0 (da) |
IS (1) | IS7006A (da) |
NO (1) | NO20034863L (da) |
NZ (1) | NZ529586A (da) |
PL (1) | PL363313A1 (da) |
PT (1) | PT1383752E (da) |
RU (1) | RU2296755C2 (da) |
SI (1) | SI1383752T1 (da) |
WO (1) | WO2002088100A2 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10261807A1 (de) | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel |
HUP0300929A3 (en) * | 2003-04-09 | 2005-06-28 | Richter Gedeon Vegyeszet | Analgetic and/or muscle relaxant pharmaceutical composition |
DE102005014080B4 (de) * | 2005-03-21 | 2007-11-22 | Birds Pharma Gmbh Berolina Innovative Research & Development Services | Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel |
CN101268050B (zh) * | 2005-07-26 | 2012-11-28 | 奈科明有限责任公司 | 同位素取代的泮托拉唑 |
US7601737B2 (en) * | 2005-07-26 | 2009-10-13 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
CN101268051B (zh) * | 2005-07-26 | 2011-08-31 | 奈科明有限责任公司 | 同位素取代的质子泵抑制剂 |
EP1934201A1 (en) * | 2005-10-06 | 2008-06-25 | Auspex Pharmaceuticals Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
CA2651732C (en) | 2006-05-18 | 2014-10-14 | Mannkind Corporation | Intracellular kinase inhibitors |
AU2007286186A1 (en) * | 2006-08-08 | 2008-02-21 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
US20130197031A1 (en) * | 2010-09-03 | 2013-08-01 | IVAX International GmbH | Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
KR20230023817A (ko) | 2013-12-03 | 2023-02-17 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
CN106535898A (zh) * | 2014-04-04 | 2017-03-22 | 细胞内治疗公司 | 有机化合物 |
WO2017105881A1 (en) * | 2015-12-15 | 2017-06-22 | NeuForm Pharmaceuticals, Inc. | Deuterated compounds for treating pain |
EP3407889B1 (en) | 2016-03-25 | 2021-05-19 | Intra-Cellular Therapies, Inc. | Organic compounds and their use in treating or preventing central nervous system disorders |
JP7013454B2 (ja) | 2016-10-12 | 2022-02-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | アモルファス固体分散体 |
CN106588817A (zh) * | 2016-12-13 | 2017-04-26 | 湖南亚大制药有限公司 | 一种盐酸乙哌立松的合成方法 |
CN116327770A (zh) | 2017-03-24 | 2023-06-27 | 细胞内治疗公司 | 新组合物和方法 |
KR20210052471A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
JP7457000B2 (ja) | 2018-08-31 | 2024-03-27 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 新規方法 |
CN110845443B (zh) * | 2019-12-11 | 2023-09-05 | 嘉实(湖南)医药科技有限公司 | 一种制备高纯度盐酸托哌酮的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5527914B2 (da) * | 1973-12-14 | 1980-07-24 | ||
US3995047A (en) * | 1973-12-14 | 1976-11-30 | Eisai Co., Ltd. | Propiophenone derivatives in the treatment of pathological muscular conditions |
HU33131A (da) * | 1984-01-26 | 1984-10-29 |
-
2001
- 2001-05-02 DE DE10123129A patent/DE10123129A1/de not_active Withdrawn
-
2002
- 2002-04-29 HU HU0400077A patent/HUP0400077A2/hu unknown
- 2002-04-29 KR KR1020037014301A patent/KR100894846B1/ko not_active IP Right Cessation
- 2002-04-29 CN CNA2006101485698A patent/CN101002770A/zh active Pending
- 2002-04-29 PL PL02363313A patent/PL363313A1/xx unknown
- 2002-04-29 CZ CZ20033060A patent/CZ20033060A3/cs unknown
- 2002-04-29 US US10/476,743 patent/US7307091B2/en not_active Expired - Lifetime
- 2002-04-29 JP JP2002585402A patent/JP4373097B2/ja not_active Expired - Fee Related
- 2002-04-29 RU RU2003133924/04A patent/RU2296755C2/ru not_active IP Right Cessation
- 2002-04-29 CN CNB028106121A patent/CN1293064C/zh not_active Expired - Fee Related
- 2002-04-29 PT PT02727303T patent/PT1383752E/pt unknown
- 2002-04-29 ES ES02727303T patent/ES2244768T3/es not_active Expired - Lifetime
- 2002-04-29 EP EP02727303A patent/EP1383752B1/de not_active Expired - Lifetime
- 2002-04-29 IL IL15866802A patent/IL158668A0/xx unknown
- 2002-04-29 AU AU2002257562A patent/AU2002257562B2/en not_active Ceased
- 2002-04-29 NZ NZ529586A patent/NZ529586A/en unknown
- 2002-04-29 SI SI200230177T patent/SI1383752T1/sl unknown
- 2002-04-29 DE DE50203456T patent/DE50203456D1/de not_active Expired - Lifetime
- 2002-04-29 DK DK02727303T patent/DK1383752T3/da active
- 2002-04-29 AT AT02727303T patent/ATE298324T1/de not_active IP Right Cessation
- 2002-04-29 WO PCT/DE2002/001607 patent/WO2002088100A2/de active IP Right Grant
- 2002-04-29 CA CA2446890A patent/CA2446890C/en not_active Expired - Fee Related
-
2003
- 2003-10-30 IS IS7006A patent/IS7006A/is unknown
- 2003-10-31 NO NO20034863A patent/NO20034863L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2003133924A (ru) | 2005-05-10 |
AU2002257562B2 (en) | 2007-01-11 |
DE50203456D1 (de) | 2005-07-28 |
DE10123129A1 (de) | 2002-11-14 |
SI1383752T1 (sl) | 2005-12-31 |
CZ20033060A3 (cs) | 2004-09-15 |
KR20040015240A (ko) | 2004-02-18 |
US7307091B2 (en) | 2007-12-11 |
CN1527823A (zh) | 2004-09-08 |
WO2002088100A2 (de) | 2002-11-07 |
NZ529586A (en) | 2005-07-29 |
US20040186136A1 (en) | 2004-09-23 |
PL363313A1 (en) | 2004-11-15 |
ATE298324T1 (de) | 2005-07-15 |
CN1293064C (zh) | 2007-01-03 |
JP4373097B2 (ja) | 2009-11-25 |
PT1383752E (pt) | 2005-11-30 |
KR100894846B1 (ko) | 2009-04-24 |
CA2446890A1 (en) | 2002-11-07 |
RU2296755C2 (ru) | 2007-04-10 |
WO2002088100A3 (de) | 2003-05-30 |
CA2446890C (en) | 2010-02-23 |
JP2004527558A (ja) | 2004-09-09 |
EP1383752B1 (de) | 2005-06-22 |
IS7006A (is) | 2003-10-30 |
NO20034863D0 (no) | 2003-10-31 |
CN101002770A (zh) | 2007-07-25 |
IL158668A0 (en) | 2004-05-12 |
EP1383752A2 (de) | 2004-01-28 |
NO20034863L (no) | 2003-12-30 |
HUP0400077A2 (hu) | 2004-04-28 |
ES2244768T3 (es) | 2005-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
SE0001899D0 (sv) | New compounds | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
BR0015188A (pt) | Composições farmacêuticas | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
WO2004032909A3 (en) | Stabilized pharmaceutical composition containing basic excipients | |
DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
NO20063277L (no) | Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav | |
HUP0402304A2 (hu) | Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények | |
SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
SE0102440D0 (sv) | New compound | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
UY27373A1 (es) | Formulaciones de interferón beta-humano | |
SE0001916D0 (sv) | Novel formulation | |
DK1268522T3 (da) | LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler | |
MY136382A (en) | Use of cholesterol-lowering agent | |
GEP20043377B (en) | Pharmaceutical Complex | |
HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
HUP0402062A2 (hu) | Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények | |
BR0112690A (pt) | Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos | |
SE0203817D0 (sv) | New composition | |
IT1306186B1 (it) | Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale |